Trusted Trader Program Pairs FDA With Customs To Expedite Imports
This article was originally published in The Tan Sheet
Executive Summary
The Trusted Trader program would create some incentives to companies willing to ensure their supply chains are secure, but is similar to a program FDA already has in place.
You may also be interested in...
FDA Envisions International Focus Groups Navigating Globalization Issues
FDA could help create several international coalitions to carry out the agency’s globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors.
Keeping Track: More Rx-To-OTC Switches On Deck After US FDA’s OTC Narcan Approval; Iovance Looks To Bring Cell Therapy To Melanoma
The latest drug development news and highlights form the Pink Sheet’s US FDA Performance Tracker.
Finance Watch: LSP Dementia Fund Closes With €260m For Neurodegenerative Diseases
EQT Life Sciences completed the final close of its inaugural LSP Dementia Fund, far surpassing an initial $100m fundraising goal. Also, Resilience received a $410m commitment from the Department of Defense to fund biomanufacturing and Viking cashed in on Phase I obesity data with a $250m offering.